1Leonard, BE (2001) Stress, norepinephrine and depression. J Psychiatry Neurosci 26, S11–S16.
2Lesperance, F & Frasure-Smith, N (2000) Depression in patients with cardiac disease: a practical review. J Psychosom Res 48, 379–391.
3Ketterer, MW, Mahr, G & Goldberg, AD (2000) Psychological factors affecting a medical condition: ischemic coronary heart disease. J Psychosom Res 48, 357–367.
4Newport, DJ & Nemeroff, CB (1998) Assessment and treatment of depression in the cancer patient. J Psychosom Res 45, 215–237.
5Spiegel, D (1996) Cancer and depression. Br J Psychiatry Suppl 168, Suppl. 30, 109–116.
6Talbot, F & Nouwen, A (2000) A review of the relationship between depression and diabetes in adults: is there a link? Diabetes Care 23, 1556–1562.
7Kawakami, N, Takatsuka, N, Shimizu, H, et al. (1999) Depressive symptoms and occurrence of type 2 diabetes among Japanese men. Diabetes Care 22, 1071–1076.
8Cuffel, B, Wamboldt, M, Borish, L, et al. (1999) Economic consequences of comorbid depression, anxiety, and allergic rhinitis. Psychosomatics 40, 491–496.
9Bell, IR, Jasnoski, ML, Kagan, J, et al. (1991) Depression and allergies: survey of a nonclinical population. Psychother Psychosom 55, 24–31.
10Moller, P, Wallin, H & Knudsen, LE (1996) Oxidative stress associated with exercise, psychological stress and life-style factors. Chem Biol Interact 102, 17–36.
11Soory, M (2009) Relevance of nutritional antioxidants in metabolic syndrome, ageing and cancer: potential for therapeutic targeting. Infect Disord Drug Targets 9, 400–414.
12Campbell, DR, Gross, MD, Martini, MC, et al. (1994) Plasma carotenoids as biomarkers of vegetable and fruit intake. Cancer Epidemiol Biomarkers Prev 3, 493–500.
13Stryker, WS, Kaplan, LA, Stein, EA, et al. (1988) The relation of diet, cigarette smoking, and alcohol consumption to plasma beta-carotene and alpha-tocopherol levels. Am J Epidemiol 127, 283–296.
14Rao, AV & Rao, LG (2007) Carotenoids and human health. Pharmacol Res 55, 207–216.
15Paolisso, G, D'Amore, A, Balbi, V, et al. (1994) Plasma vitamin C affects glucose homeostasis in healthy subjects and in non-insulin-dependent diabetics. Am J Physiol Endocrinol Metab 266, E261–E268.
16Ford, ES, Mokdad, AH, Giles, WH, et al. (2003) The metabolic syndrome and antioxidant concentrations: findings from the Third National Health and Nutrition Examination Survey. Diabetes 52, 2346–2352.
17Sies, H & Stahl, W (1995) Vitamins E and C, beta-carotene, and other carotenoids as antioxidants. Am J Clin Nutr 62, Suppl. 6, 1315S–1321S.
18Liu, J, Wang, X & Mori, A (1994) Immobilization stress-induced antioxidant defense changes in rat plasma: effect of treatment with reduced glutathione. Int J Biochem 26, 511–517.
19Davydov, VV & Shvets, VN (2001) Lipid peroxidation in the heart of adult and old rats during immobilization stress. Exp Gerontol 36, 1155–1160.
20Matsumoto, K, Yobimoto, K, Huong, NT, et al. (1999) Psychological stress-induced enhancement of brain lipid peroxidation via nitric oxide systems and its modulation by anxiolytic and anxiogenic drugs in mice. Brain Res 839, 74–84.
21Cernak, I, Savic, V, Kotur, J, et al. (2000) Alterations in magnesium and oxidative status during chronic emotional stress. Magnes Res 13, 29–36.
22Tsuboi, H, Shimoi, K, Kinae, N, et al. (2004) Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J Psychosom Res 56, 53–58.
23Irwin, M (1999) Immune correlates of depression. Adv Exp Med Biol 461, 1–24.
24Maddock, C & Pariante, CM (2001) How does stress affect you? An overview of stress, immunity, depression and disease. Epidemiol Psichiatr Soc 10, 153–162.
25Craft, NE, Haitema, TB, Garnett, KM, et al. (2004) Carotenoid, tocopherol, and retinol concentrations in elderly human brain. J Nutr Health Aging 8, 156–162.
26Oishi, J, Doi, H & Kawakami, N (2009) Nutrition and depressive symptoms in community-dwelling elderly persons in Japan. Acta Med Okayama 63, 9–17.
27Maes, M, De Vos, N, Pioli, R, et al. (2000) Lower serum vitamin E concentrations in major depression. Another marker of lowered antioxidant defenses in that illness. J Affect Disord 58, 241–246.
28Owen, AJ, Batterham, MJ, Probst, YC, et al. (2005) Low plasma vitamin E levels in major depression: diet or disease? Eur J Clin Nutr 59, 304–306.
29Sher, L (2008) Depression and suicidal behavior in alcohol abusing adolescents: possible role of selenium deficiency. Minerva Pediatr 60, 201–209.
30Tiemeier, H, Hofman, A, Kiliaan, AJ, et al. (2002) Vitamin E and depressive symptoms are not related. The Rotterdam Study. J Affect Disord 72, 79–83.
31Shibata, H, Kumagai, S, Watanabe, S, et al. (1999) Relationship of serum cholesterols and vitamin E to depressive status in the elderly. J Epidemiol 9, 261–267.
32Milaneschi, Y, Bandinelli, S, Penninx, BW, et al. (2011) The relationship between plasma carotenoids and depressive symptoms in older persons. World J Biol Psychiatry .
33Ogden, CL, Carroll, MD, Curtin, LR, et al. (2006) Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 295, 1549–1555.
34 Center for Disease Control and Prevention (CDC) (2006) National Health and Nutrition Examination Survey. http://www.cdc.gov/nchs/nhanes.htm (accessed 25 September 2006, updated 2006, cited 25 September 2006).
35Kroenke, K, Spitzer, RL & Williams, JB (2001) The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 16, 606–613.
36Spitzer, RL, Kroenke, K & Williams, JB (1999) Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary Care Evaluation of Mental Disorders. Patient Health Questionnaire. JAMA 282, 1737–1744.
37Centers for Disease Control and Prevention (CDC) (2009) National Health and Nutrition Examination Surveys (NHANES 2005–06): Laboratory Procedure Manual: Fat Soluble Micronutrients (Vitamins A, E and Carotenoids) – UV–Visible Detection. Hyatsville, MD: Centers for Disease Control and Prevention. http://www.cdc.gov/nchs/data/nhanes/nhanes_05_06/vitaec_d_met_aecar.pdf .
39Cheng, YJ, Gregg, EW, De Rekeneire, N, et al. (2007) Muscle-strengthening activity and its association with insulin sensitivity. Diabetes Care 30, 2264–2270.
40Lagerros, YT & Lagiou, P (2007) Assessment of physical activity and energy expenditure in epidemiological research of chronic diseases. Eur J Epidemiol 22, 353–362.
41McCullough, ML, Feskanich, D, Rimm, EB, et al. (2000) Adherence to the dietary guidelines for Americans and risk of major chronic disease in men. Am J Clin Nutr 72, 1223–1231.
43Silvers, KM & Scott, KM (2002) Fish consumption and self-reported physical and mental health status. Public Health Nutr 5, 427–431.
44Hasin, DS & Glick, H (1993) Depressive symptoms and DSM-III-R alcohol dependence: general population results. Addiction 88, 1431–1436.
45Raimo, EB & Schuckit, MA (1998) Alcohol dependence and mood disorders. Addict Behav 23, 933–946.
46United States Department of Agriculture (USDA) (2007) Agriculture Research Service. MyPyramid Equivalents Database for USDA Survey Food Codes version 1.0. Beltsville, MD: USDA. http://www.ars.usda.gov/Services/docs.htm?docid = 8503 (accessed accessed July 2007, updated 2007, cited).
50Pernet, P, Lasnier, E & Vaubourdolle, M (2000) Evaluation of the AxSYM homocysteine assay and comparison with the IMx homocysteine assay. Clin Chem 46, 1440–1441.
52Wilkins, CH, Sheline, YI, Roe, CM, et al. (2006) Vitamin D deficiency is associated with low mood and worse cognitive performance in older adults. Am J Geriatr Psychiatry 14, 1032–1040.
53Forti, P, Rietti, E, Pisacane, N, et al. (2010) Blood homocysteine and risk of depression in the elderly. Arch Gerontol Geriatr 51, 21–25.
54Almeida, OP, McCaul, K, Hankey, GJ, et al. (2008) Homocysteine and depression in later life. Arch Gen Psychiatry 65, 1286–1294.
55Tiemeier, H, van Tuijl, HR, Hofman, A, et al. (2002) Vitamin B12, folate, and homocysteine in depression: the Rotterdam Study. Am J Psychiatry 159, 2099–2101.
56Bottiglieri, T, Laundy, M, Crellin, R, et al. (2000) Homocysteine, folate, methylation, and monoamine metabolism in depression. J Neurol Neurosurg Psychiatry 69, 228–232.
57Dimopoulos, N, Piperi, C, Salonicioti, A, et al. (2007) Correlation of folate, vitamin B12 and homocysteine plasma levels with depression in an elderly Greek population. Clin Biochem 40, 604–608.
58Kim, JM, Stewart, R, Kim, SW, et al. (2008) Predictive value of folate, vitamin B12 and homocysteine levels in late-life depression. Br J Psychiatry 192, 268–274.
59Nanri, A, Mizoue, T, Matsushita, Y, et al. (2010) Serum folate and homocysteine and depressive symptoms among Japanese men and women. Eur J Clin Nutr 64, 289–296.
60Kendrick, T, Dunn, N, Robinson, S, et al. (2008) A longitudinal study of blood folate levels and depressive symptoms among young women in the Southampton Women's Survey. J Epidemiol Community Health 62, 966–972.
61Beydoun, MA, Fanelli Kuczmarski, MT, Beydoun, HA, et al. (2010) The sex-specific role of plasma folate in mediating the association of dietary quality with depressive symptoms. J Nutr 140, 338–347.
62Sachdev, PS, Parslow, RA, Lux, O, et al. (2005) Relationship of homocysteine, folic acid and vitamin B12 with depression in a middle-aged community sample. Psychol Med 35, 529–538.
63Bjelland, I, Tell, GS, Vollset, SE, et al. (2003) Folate, vitamin B12, homocysteine, and the MTHFR 677C → T polymorphism in anxiety and depression: the Hordaland Homocysteine Study. Arch Gen Psychiatry 60, 618–626.
64Kim, JM, Kim, SW, Shin, IS, et al. (2008) Folate, vitamin B(12), and homocysteine as risk factors for cognitive decline in the elderly. Psychiatry Investig 5, 36–40.
65Astorg, P, Couthouis, A, de Courcy, GP, et al. (2008) Association of folate intake with the occurrence of depressive episodes in middle-aged French men and women. Br J Nutr 100, 183–187.
66Sanchez-Villegas, A, Doreste, J, Schlatter, J, et al. (2009) Association between folate, vitamin B(6) and vitamin B(12) intake and depression in the SUN cohort study. J Hum Nutr Diet 22, 122–133.
67Tolmunen, T, Hintikka, J, Ruusunen, A, et al. (2004) Dietary folate and the risk of depression in Finnish middle-aged men. A prospective follow-up study. Psychother Psychosom 73, 334–339.
68Beydoun, MA, Shroff, MR, Beydoun, HA, et al. (2010) Serum folate, vitamin B-12, and homocysteine and their association with depressive symptoms among U.S. adults. Psychosom Med 72, 862–873.
69Beydoun, MA, Shroff, MR, Chen, X, et al. (2011) Serum antioxidant status is associated with metabolic syndrome among U.S. adults in recent national surveys. J Nutr 141, 903–913.
70Long, JS (1997) Regression Models for Categorical and Limited Dependent Variables. Thousand Oaks, CA: Sage.
71Bandiera, FC, Arheart, KL, Caban-Martinez, AJ, et al. (2010) Secondhand smoke exposure and depressive symptoms. Psychosom Med 72, 68–72.
72Selvin, S (2004) Statistical Analysis of Epidemiologic Data, 3rd ed.New York: Oxford University Press.
73Lohr, SL (2010) Sampling: Design and Analysis, 2nd ed.Pacific Grove, CA: Brooks/Cole.
74Heckman, JJ (1979) Sample selection bias as a specification error. Econometrica 47, 153–161.
75Puhani, P (2000) The Heckman correction for sample selection and its critique. J Econ Surveys 14, 53–68.
76Wang, Z (2007) Two postestimation commands for assessing confounding effects in epidemiological studies. Stata J 7, 183–196.
77Halliwell, B (2006) Oxidative stress and neurodegeneration: where are we now? J Neurochem 97, 1634–1658.
78Valko, M, Leibfritz, D, Moncol, J, et al. (2007) Free radicals and antioxidants in normal physiological functions and human disease. Int J Biochem Cell Biol 39, 44–84.
79Florence, TM (1995) The role of free radicals in disease. Aust N Z J Ophthalmol 23, 3–7.
80Mason, RP, Walter, MF & Mason, PE (1997) Effect of oxidative stress on membrane structure: small-angle X-ray diffraction analysis. Free Radic Biol Med 23, 419–425.
81Tirosh, O, Kohen, R, Katzhendler, J, et al. (1997) Oxidative stress effect on the integrity of lipid bilayers is modulated by cholesterol level of bilayers. Chem Phys Lipids 87, 17–22.
82Maes, M, Galecki, P, Chang, YS, et al. (2011) A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness. Prog Neuropsychopharmacol Biol Psychiatry 35, 676–692.